SMYD3
Histone-lysine N-methyltransferase SMYD3
Also known as: KMT3E, SMYD3_HUMAN, ZMYND1, ZNFN3A1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H7B4
- Gene
- SMYD3
- Ensembl
- ENSG00000185420
- Chromosome
- 1
- Canonical length
- 428 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a histone methyltransferase which functions in RNA polymerase II complexes by an interaction with a specific RNA helicase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
428 residues, UniProt reviewed canonical sequence.
>Q9H7B4|SMYD3
1 MEPLKVEKFA TAKRGNGLRA VTPLRPGELL FRSDPLAYTV CKGSRGVVCD RCLLGKEKLM
61 RCSQCRVAKY CSAKCQKKAW PDHKRECKCL KSCKPRYPPD SVRLLGRVVF KLMDGAPSES
121 EKLYSFYDLE SNINKLTEDK KEGLRQLVMT FQHFMREEIQ DASQLPPAFD LFEAFAKVIC
181 NSFTICNAEM QEVGVGLYPS ISLLNHSCDP NCSIVFNGPH LLLRAVRDIE VGEELTICYL
241 DMLMTSEERR KQLRDQYCFE CDCFRCQTQD KDADMLTGDE QVWKEVQESL KKIEELKAHW
301 KWEQVLAMCQ AIISSNSERL PDINIYQLKV LDCAMDACIN LGLLEEALFY GTRTMEPYRI
361 FFPGSHPVRG VQVMKVGKLQ LHQGMFPQAM KNLRLAFDIM RVTHGREHSL IEDLILLLEE
421 CDANIRASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SMYD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 21 nTPM
- cerebellum: 19 nTPM
- cerebral cortex: 15 nTPM
- thyroid gland: 15 nTPM
- basal ganglia: 15 nTPM
- hypothalamus: 14 nTPM
Single-cell type
- mast cells: 1,384 nCPM
- thyrotrophs: 1,211 nCPM
- cone photoreceptor cells: 1,161 nCPM
- choroid plexus epithelial cells: 1,024 nCPM
- brain excitatory neurons: 1,022 nCPM
- brain inhibitory neurons: 957 nCPM
Immune cell
- NK-cell: 28 nTPM
- memory CD8 T-cell: 16 nTPM
- T-reg: 16 nTPM
- naive CD8 T-cell: 16 nTPM
- naive B-cell: 16 nTPM
- naive CD4 T-cell: 15 nTPM
Brain region
- cerebellum: 44 nTPM
- hypothalamus: 34 nTPM
- midbrain: 32 nTPM
- hippocampal formation: 32 nTPM
- pons: 31 nTPM
- basal ganglia: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.24
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to dexamethasone stimulus
- establishment of protein localization
- methylation
- myotube cell development
- nucleosome assembly
- positive regulation of transcription by RNA polymerase II
Molecular functions
- histone H3K36 dimethyltransferase activity
- histone H3K4 trimethyltransferase activity
- histone H4 methyltransferase activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II complex binding
- RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Zinc finger, MYND-type
- Tetratricopeptide-like helical domain superfamily
- SET domain superfamily
- Histone-lysine N-methyltransferase
- SET domain
- MYND finger
- Histone-lysine N-methyltransferase SMYD3
- SMYD3, SET domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SMYD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SMYD3 as an antibody target. Whether an autoantibody or antibody against SMYD3 could matter depends on whether native SMYD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SMYD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SMYD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...